A Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With Type 2 Diabetes Mellitus
Stopped The study was stopped due to lack of recruitment.
Conditions
- Type II Diabetes Mellitus
Interventions
- OTHER: Use of digital disease management tool in participants with T2DM
Sponsor
AstraZeneca
Collaborators